fashion -WSS

fashion

author：fashion 2025-09-03 14:40:04 - browse：43616

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： The Readout: Lenmeldy, GLP

WSS

Attacks on the drug industry will lead to fewer breakthroughs

Abortion pill case raises question: who can sue the FDA?

Donor acceptance rates hint at racial, gender bias in heart transplants: study

States should stop sabotaging methadone treatment reform

Oprah kicked off a national conversation on obesity. Let's have it

Food as medicine: Medically tailored meals may get standardized

hotspot

fashion

The need-to-know this morning

Is it time to worry about Moderna?

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Merck, Vertex, and Viking updates

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why the world’s most expensive drug might be worth the price

Anesthesiologist group: stop taking Ozempic before surgery

Study says nonprofit hospitals fall short in charity care spending

Hollywood unions extend contract negotiations for actors

Biden calls for immediate release of Niger's president amid apparent coup

Psychedelics group wrestles with new pharma identity

Roche subsidiary Foundation Medicine opens new headquarters

hotspot

My superpower is killing ticks

What Henrietta Lacks settlement says about racism in medicine

Food as medicine: Medically tailored meals may get standardized

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

White House drug shortage group privately met with industry

Abortion pill case raises question: who can sue the FDA?

entertainment

leisure time

entertainment

focus